7-92623037-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP2BP4

The NM_001145306.2(CDK6):​c.697G>A​(p.Asp233Asn) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000000704 in 1,419,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.0e-7 ( 0 hom. )

Consequence

CDK6
NM_001145306.2 missense, splice_region

Scores

2
5
12
Splicing: ADA: 0.9542
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.24
Variant links:
Genes affected
CDK6 (HGNC:1777): (cyclin dependent kinase 6) The protein encoded by this gene is a member of the CMGC family of serine/threonine protein kinases. This kinase is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression and G1/S transition. The activity of this kinase first appears in mid-G1 phase, which is controlled by the regulatory subunits including D-type cyclins and members of INK4 family of CDK inhibitors. This kinase, as well as CDK4, has been shown to phosphorylate, and thus regulate the activity of, tumor suppressor protein Rb. Altered expression of this gene has been observed in multiple human cancers. A mutation in this gene resulting in reduced cell proliferation, and impaired cell motility and polarity, and has been identified in patients with primary microcephaly. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CDK6. . Gene score misZ 3.0596 (greater than the threshold 3.09). Trascript score misZ 3.1324 (greater than threshold 3.09). GenCC has associacion of gene with autosomal recessive primary microcephaly, microcephaly 12, primary, autosomal recessive.
BP4
Computational evidence support a benign effect (MetaRNN=0.29606402).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CDK6NM_001145306.2 linkuse as main transcriptc.697G>A p.Asp233Asn missense_variant, splice_region_variant 6/8 ENST00000424848.3 NP_001138778.1
CDK6NM_001259.8 linkuse as main transcriptc.697G>A p.Asp233Asn missense_variant, splice_region_variant 6/8 NP_001250.1
CDK6XM_047419716.1 linkuse as main transcriptc.697G>A p.Asp233Asn missense_variant, splice_region_variant 6/8 XP_047275672.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CDK6ENST00000424848.3 linkuse as main transcriptc.697G>A p.Asp233Asn missense_variant, splice_region_variant 6/81 NM_001145306.2 ENSP00000397087 P1
CDK6ENST00000265734.8 linkuse as main transcriptc.697G>A p.Asp233Asn missense_variant, splice_region_variant 6/81 ENSP00000265734 P1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.04e-7
AC:
1
AN:
1419832
Hom.:
0
Cov.:
25
AF XY:
0.00000142
AC XY:
1
AN XY:
706634
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000120
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 18, 2023The c.697G>A (p.D233N) alteration is located in exon 6 (coding exon 5) of the CDK6 gene. This alteration results from a G to A substitution at nucleotide position 697, causing the aspartic acid (D) at amino acid position 233 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.54
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.35
T;T
Eigen
Benign
0.041
Eigen_PC
Uncertain
0.25
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.96
.;D
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.30
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.14
N;N
MutationTaster
Benign
1.0
D;D
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-1.7
N;N
REVEL
Benign
0.14
Sift
Uncertain
0.018
D;D
Sift4G
Uncertain
0.031
D;D
Polyphen
0.078
B;B
Vest4
0.41
MutPred
0.45
Gain of methylation at K230 (P = 0.0694);Gain of methylation at K230 (P = 0.0694);
MVP
0.44
MPC
1.1
ClinPred
0.89
D
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.66
gMVP
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.95
dbscSNV1_RF
Benign
0.65
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr7-92252351; API